Here are relevant reports on : clinical-documentation-improvement-market
-
Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029
The global antimicrobial susceptibility testing market, valued at US$4.28 billion in 2023, stood at US$4.45 billion in 2024 and is projected to advance at a resilient CAGR of 5.0% from 2024 to 2029, culminating in a forecasted valuation of US$5.68 billion by the end of the period. Major driving factors for market growth include the increasing prevalence of antibiotic-resistant infections and a greater demand for effective treatments.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Cognitive Assessment and Training in Healthcare Market by Assessment Type (Pen-and-Paper Based, Hosted, and Biometrics), Components, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), & Region - Global forecast to 2021
Cognitive impairment can occur in early childhood or late adulthood. There are various reasons for it, which can be reversible or irreversible. Early causes may include malnutrition, prenatal drug exposure, genetic syndromes, and chromosome abnormalities. The brain retains its neuroplasticity till late adulthood; therefore, there has been a growing demand for cognitive assessment and training. MarketsandMarkets predicts the global cognitive assessment and training in healthcare market to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. The year 2015 has been considered as the base year, while the forecast period is 2016–2021.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Animal Protein Ingredients Market By Type (Dairy, Egg, Gelatin), Application (Dairy, Clinical Nutrition, Dietetic & Sports Food, Confectionery, Beverages, Meat, Bakery), By Geography: Trends & Forecasts To 2018
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, Cardio, GI, OBGYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2030
The global near IR imaging market, valued at US$9.69 billion in 2023, stood at US$1.25 billion in 2025 and is projected to advance at a resilient CAGR of 10.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.07 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global Digital PCR and qPCR market, valued at US$9.4 billion in 2023, stood at US$10.0 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.8 billion by the end of the period. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery, and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Neuromarketing Tools, Technologies, & Services Market by Tool (Hardware Solution, Software Platform), Technology (EEG & Brainware Monitoring, Biometric & Physiological Monitoring), End Users (Clinical Research, Consumer Research) - Global Forecast to 2030
The neuromarketing tools, technologies, and services market is segmented by tools (hardware solutions like EEG amplifiers, eye-tracking, biometric devices, and software platforms), technologies (EEG & brainwave monitoring, eye-tracking, biometric & physiological monitoring), and end users (commercial & enterprise solutions, consumer research, academic & clinical research, and others). Market estimates are derived through extensive secondary and primary research, applying top-down and bottom-up approaches with data triangulation. The study covers global and regional market dynamics, competitive landscape, and forecasts up to 2030, profiling key players such as Tobii AB, iMotions, EMOTIV, Brain Products, Smart Eye, and others.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Laboratoray Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030
The global laboratory centrifuges market, valued at US$1.53 billion in 2024, stood at US$1.58 billion in 2025 and is projected to advance at a resilient CAGR of 2.8% from 2024 to 2030, culminating in a forecasted valuation of US$1.86 billion by the end of the period. This growth is driven by increased R&D investments and research grants, technological advancements and innovative rotor designs, a rise in infectious diseases that boosts sample testing and cell-based research, and expanding applications of these centrifuges.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
